The Latest Cardiac and Vascular News
January 07, 2025 07:05 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its ECG-based, AI-powered AK+ Guard™ hyperkalemia […]
This investment will support AccurKardia’s mission to deliver world class clinical-grade ECG interpretation software to cardiac monitoring companies, thereby expanding access to the benefits of remote cardiac care to millions of patients worldwide. June 20, 2023 01:11 PM Eastern Daylight […]
The two leading innovative companies have announced a landmark agreement to equip Mawi’s new cardiac monitoring watch with AccurKardia’s automated ECG analytics NEW YORK & LONDON–(BUSINESS WIRE)–AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocardiogram (ECG) analytics, announced […]
New study published on JMIR Formative Research showcases clinical performance of AccurKardia’s AccurBeat platform for QT/QTc remote monitoring using smartwatch ECG data NEW YORK–(BUSINESS WIRE)–AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the […]
American Heart Association consortium advances development of evidence-based health tech solutions NEW YORK–(BUSINESS WIRE)–AccurKardia, a software company that provides device-agnostic and automated ECG analytics, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. […]
NEW YORK & RINCON, Puerto Rico–(BUSINESS WIRE)–AccurKardia, Inc., a software company that provides clinical-grade, device agnostic, automated ECG analytics, today announced a collaboration with MDF Instruments, a highly-regarded and longstanding medical supplier, to develop ECG (electrocardiogram) solutions for the next generation […]
